FDA Approves First Autoinjector for At-Home IV-Equivalent Diuresis
FDA Approves First Autoinjector for At-Home IV-Equivalent Diuresis The American Journal of Managed Care
US FDA approves Outlook Therapeutics’ eye disease drug
US FDA approves Outlook Therapeutics' eye disease drug Reuters
FDA approves acetaminophen-naproxen sodium combination tablet for ages 12 and older
FDA approves acetaminophen-naproxen sodium combination tablet for ages 12 and older Contemporary Pediatrics
FDA Approves First OTC Acetaminophen–Naproxen Combination for 12-Hour Pain Relief
FDA Approves First OTC Acetaminophen–Naproxen Combination for 12-Hour Pain Relief Pharmacy Times